The aim is to formalize and disseminate the standards of behavior that guide all actions in the performance of our work and reflect our commitment to ethics within business. Our performance is measured by the results and the way they are achieved. It is important to mention that our Code of Conduct applies to all Maypo directors and associates.
All managers and collaborators must respond to and sign the Code of Conduct Compliance Manifesto upon entering the company, which is updated by each manager or collaborator annually.
The purpose of the code is to communicate the company’s expectations of business ethics, held by Farmacéuticos Maypo, when doing business or collaborative projects with Business Partners, Distributors and Suppliers.
In Maypo Business Ethics has been a fundamental pillar of the present that we have achieved and that fills us with pride, but it is also an inseparable element of the way in which we are committed to building our future and facing the challenges that arise.
With the objectives of ensuring compliance with the obligations acquired with Authorities, Business Partners, Clients, Shareholders, Directors and Society in general; ensure ethical behaviour in our business activities; protect maypo's reputation, we implement a Compliance Program based on our values: Excellence, Integrity, Innovation, Human Sense, Transparency and Frugality.
Our Program is integrated by a series of Policies aligned with the ethical standards required by the codes of the pharmaceutical industry and national and international legislation on anti-corruption, training programs on these policies that are universally applicable, communication campaigns, supervisory activities through the monitoring and auditing of sensitive processes and the existence and availability of internal and external communication channels that allow the anonymous and confidential treatment of the complaints received.
The Compliance team one hundred percent dedicated to this function with a reporting line to the Board of Directors and the message emanating from senior management complement the operation of the program.
Knowing that Maypo, in its role as distributor and logistics expert, is a key player in the value chain that reaches institutions and patients, medicines and strategic solutions for human health, by implementing the Compliance Program we ensure to be part of the chain of trust that contributes to the ethical sustainability of the Mexican pharmaceutical logistics industry.
Anti-Bribery and Anti-Corruption Policy
Our Policy is intended to ensure that all our negotiations and operations with third parties, in particular with governments and government officials, are conducted in compliance with all relevant laws and regulations, ensuring that we adhere to the highest standards of business integrity. This Policy applies to all Farmacéuticos Maypo directors and collaborators, as well as third parties with whom we have commercial relations, and it gives clarity of the guidelines and mechanisms of prevention, detection, and immediate response to any acts of corruption that may arise in our activities.
All directors and collaborators must respond to and sign the Anti-Corruption Manifesto upon entering the company, which is updated by each manager or collaborator annually.
The policy includes a Due Diligence* process, which consists of a series of revisions prior to the signing of a contract or the start of a business. To evaluate the third party for the purpose of mitigating risks of linking with natural or moral persons not aligned with our business ethics standards.
Because of the nature of Farmacéuticos Maypo’s business, we do not carry out any activities that could be subject of vulnerability to illicit origins or cash transactions.
Farmacéuticos Maypo, emphasizes having "zero tolerance and prohibition of corrupt practices, bribery and facilitation payments", We therefore make the "complaint line" available to all collaborators and third parties in order that they may report any violation of our policies or national or international law.
It is a mandate of the Board of Directors that day-to-day business activities are integral and transparent, and therefore it is an obligation of the Chief Compliance Officer to report to the Board on activities related to the Compliance Program.
Monitoring of Compliance Program and Corrupt Practices Prevention activities is included in the Annual Internal Audit Plan, which is approved by the Internal Audit Committee.
ISO 9001:2015 certification process.
Prevention of Money Laundering and Resources of Illicit Origin
Farmacéuticos Maypo rejects any financial transaction that is intended to operate on money or goods that have been acquired through illegal acts or transactions seeking to give it a legally apparent origin.
Even though Maypo does not carry out vulnerable operations in accordance with the Mexican Federal Law for the Prevention and Identification of Operations with Illicit Proceeds (LFPIORPI), we have established the following preventive guidelines focused on preventing money laundering:
This Policy establishes guidelines of conduct that govern our business interactions with Administrative Personnel and the manner in which we conduct them, in accordance with our values, policies, local and international laws and regulations.
This policy applies to all Commercial Interaction activities, carried out by any director and collaborator of Farmacéuticos Maypo and third parties acting on its behalf.
Maypo is committed to social responsibility actions and supports, through donations, various programs to support the community, vulnerable groups and projects that promote diversity and inclusion.
These actions are regulated in the Grants and Subsidies Policy which defines the guidelinesby which we make decisions regarding Maypo's participation in community projects, institutions and humanitarian crisis situations. The Policy expressly prohibits making donations to political parties. This Policy applies to all directors and collaborators of Maypo.
This Policy applies to all directors and collaborators of Farmacéuticos Maypo and establishes the principles with which interactions with government officials should be carried out, from their intent, definition of purpose, to documentation of the results and actions resulting from the interaction. Our goal is to ensure that all negotiations and operations of Farmacéutica Maypo with government officials are conducted in compliance with all national and international laws and regulations, and in accordance with the highest standards of integrity required in conducting business, as stated in our Code of Conduct.
Establish internal guidelines that employees must follow in relation to the approval and verification of travel expenses and local expenses arising from the activities of the business and ensure timely monitoring of them.
Our Policy establishes the application of sanctions derived from behaviors and conducts that depart from our values and violate our Code of Conduct, our Policies, Procedures and/or applicable local or international legislation.
All associates and managers participate in the training program included in the company's entry and induction process and in Compliance's annual training program, which includes the following policies:
All employees and managers participate in the anti-corruption training, which is part of the training program included in the process of entry and induction to the company and in the annual Compliance training, which includes the following policies:
The training ofthe Code of Conduct, the Anti-Bribery and Anti-Corruption Policy and the Conflict of Interest Policy, apply to all employees of the company, the rest of the Policies are assigned according to the job description.
Training is provided in person and/or through an e-learning platform.
The collaborator or manager must accredit the training with a minimum grade of 8.
All employees and managers must respond and sign the Anti-Corruption Manifesto, the Manifesto of Adherence to the Code of Conduct and the Manifesto of Declaration of Conflict and Interest at the time of entering the company, said manifesto is updated by each collaborator or manager annually at the end of the corresponding trainings.